JB Chemicals & Pharmaceuticals Q2 Results
- BSE: 506943
- NSE: JBCHEPHARM
- ISIN: INE572A01036
- Sector: Biotechnology & Drugs
BSE
1,805
6.15 (0.34%)
6.15 (0.34%)Volume2.51 K
Updated: Wed 22 Jan, 2025 | 15:29:11
NSE
1,80512.25 (0.68%)
12.25 (0.68%)Volume2.23 L
Updated: Wed 22 Jan, 2025 | 15:29:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,000.62 Cr.(13.48%)
- Operating Profit₹228.64 Cr.(8.17%)
- Profit After Tax₹174.57 Cr.(15.92%)
- Operating Margin22.85%(-4.68%)
Note: Comparison is on YoY basis
Quarterly - JB Chemicals & Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,000.62 | 1,004.40 | -0.38% | 881.74 | 13.48% |
| Selling/ General/ Admin Expenses Total | 170.57 | 166.91 | 2.19% | 148.28 | 15.03% |
| Depreciation/ Amortization | 41.88 | 40.78 | 2.70% | 32.17 | 30.18% |
| Other Operating Expenses Total | 221.11 | 217.37 | 1.72% | 191.75 | 15.31% |
| Total Operating Expense | 771.98 | 764.81 | 0.94% | 670.37 | 15.16% |
| Operating Income | 228.64 | 239.59 | -4.57% | 211.37 | 8.17% |
| Net Income Before Taxes | 236.53 | 239.84 | -1.38% | 208.66 | 13.36% |
| Net Income | 174.57 | 176.83 | -1.28% | 150.59 | 15.92% |
| Diluted Normalized EPS | 11.00 | 11.16 | -1.43% | 9.54 | 15.30% |